Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Syndax Pharmaceuticals | SNDX | Nov 25, 2024 | 16.73 | +3.98 |
Synergetics Inc | FTGC | Nov 25, 2024 | 23.66 | -0.88 |
Synergy CHC | SNYR | Nov 25, 2024 | 5.89 | 0.00 |
Synlogic | SYBX | Nov 25, 2024 | 1.39 | -2.80 |
Synopsys | SNPS | Nov 25, 2024 | 561.87 | -0.57 |
Synovus Financial | SNV | Nov 25, 2024 | 58.67 | +1.82 |
Synovus Financial D Pref | SNV-D | Nov 25, 2024 | 25.50 | +0.16 |
Synovus Financial E Pref | SNV-E | Nov 25, 2024 | 26.40 | +0.06 |
Syntec Optics | OPTX | Nov 25, 2024 | 0.87 | -0.85 |
Sypris Solutions | SYPR | Nov 25, 2024 | 1.39 | +0.72 |
Syra Health | SYRA | Nov 25, 2024 | 0.37 | +2.08 |
Syros Pharmaceuticals | SYRS | Nov 25, 2024 | 0.26 | -12.28 |
Sysco | SYY | Nov 25, 2024 | 76.88 | +1.44 |
System1 A | SST | Nov 25, 2024 | 0.99 | -4.81 |
T Stamp A | IDAI | Nov 25, 2024 | 0.18 | +2.56 |
T-Mobile US | TMUS | Nov 25, 2024 | 239.94 | +0.70 |
T. Rowe Price Blue Chip Growth ETF | TCHP | Nov 25, 2024 | 41.60 | +0.05 |
T. Rowe Price Dividend Growth ETF | TDVG | Nov 25, 2024 | 41.67 | +0.58 |
T. Rowe Price Equity Income ETF | TEQI | Nov 25, 2024 | 43.46 | +0.53 |
T. Rowe Price Group | TROW | Nov 25, 2024 | 122.97 | +2.61 |
T. Rowe Price Growth Stock ETF | TGRW | Nov 25, 2024 | 39.49 | +0.09 |
T2 Biosystems | TTOO | Nov 25, 2024 | 0.49 | -3.92 |
Taboola.com | TBLA | Nov 25, 2024 | 3.47 | -1.70 |
Tactile Systems Technology | TCMD | Nov 25, 2024 | 18.92 | +5.99 |
Taitron Components A | TAIT | Nov 25, 2024 | 2.67 | +4.09 |
Taiwan Fund | TWN | Nov 25, 2024 | 42.62 | -1.30 |
Taiwan Index MSCI Ishares | EWT | Nov 25, 2024 | 54.06 | -0.33 |
Taiwan Semiconductor Manufacturing ADR | TSM | Nov 25, 2024 | 185.08 | -2.63 |
Take-Two Interactive Software | TTWO | Nov 25, 2024 | 187.62 | -0.28 |
Takeda Pharmaceutical ADR | TAK | Nov 25, 2024 | 13.49 | +0.82 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.